Literature DB >> 9425900

A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.

C Charlier1, N A Singh, S G Ryan, T B Lewis, B E Reus, R J Leach, M Leppert.   

Abstract

Epileptic disorders affect about 20-40 million people worldwide, and 40% of these are idiopathic generalized epilepsies (IGEs; ref. 1). Most of the IGEs that are inherited are complex, multigenic diseases. To address basic mechanisms for epilepsies, we have focused on one well-defined class of IGEs with an autosomal-dominant mode of inheritance: the benign familial neonatal convulsions (BFNC; refs 2,3). Genetic heterogeneity of BFNC has been observed. Two loci, EBN1 and EBN2, have been mapped by linkage analysis to chromosome 20q13 (refs 5,6) and chromosome 8q24 (refs 7,8), respectively. By positional cloning, we recently identified the gene for EBN1 as KCNQ2 (ref. 9). This gene, a voltage-gated potassium channel, based on homology, is a member of the KQT-like family. Here we describe an additional member, KCNQ3. We mapped this new gene to chromosome 8, between markers D8S256 and D8S284 on a radiation hybrid map. We screened KCNQ3 for mutations in the large BFNC family previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype. The same conserved amino acid is also mutated in KVLQT1 (KCNQ1) in an LQT patient. KCNQ2, KCNQ3 and undiscovered genes of the same family of K+ channels are strong candidates for other IGEs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425900     DOI: 10.1038/ng0198-53

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  221 in total

1.  Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell.

Authors:  A A Selyanko; J K Hadley; I C Wood; F C Abogadie; P Delmas; N J Buckley; B London; D A Brown
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

2.  Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors.

Authors:  A A Selyanko; J K Hadley; I C Wood; F C Abogadie; T J Jentsch; D A Brown
Journal:  J Physiol       Date:  2000-02-01       Impact factor: 5.182

Review 3.  Genetics of childhood epilepsy.

Authors:  R Robinson; M Gardiner
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

4.  Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.

Authors:  M S Shapiro; J P Roche; E J Kaftan; H Cruzblanca; K Mackie; B Hille
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

5.  Alternative splicing of KCNQ2 potassium channel transcripts contributes to the functional diversity of M-currents.

Authors:  Z Pan; A A Selyanko; J K Hadley; D A Brown; J E Dixon; D McKinnon
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 6.  Ion channels and neurology.

Authors:  S M Zuberi; M G Hanna
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

Review 7.  Ion channel genes and human neurological disease: recent progress, prospects, and challenges.

Authors:  E C Cooper; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

8.  Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.

Authors:  A A Selyanko; J K Hadley; D A Brown
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

9.  Ion channels in health and disease. 83rd Boehringer Ingelheim Fonds International Titisee Conference.

Authors:  B A Niemeyer; L Mery; C Zawar; A Suckow; F Monje; L A Pardo; W Stuhmer; V Flockerzi; M Hoth
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

10.  An M-like outward current regulates the excitability of spinal motoneurones in the adult turtle.

Authors:  Aidas Alaburda; Jean-François Perrier; Jørn Hounsgaard
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.